| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? | Eur J Cancer | 2009 | 1.45 |
| 2 | Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. | Eur J Cancer | 2011 | 1.28 |
| 3 | Vascular endothelial growth factor in systemic capillary leak syndrome. | Am J Med | 2009 | 1.19 |
| 4 | Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. | Eur J Cancer | 2009 | 1.05 |
| 5 | Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991. | J Clin Oncol | 2010 | 1.00 |